Industrial Microbiology Global Market Report 2024

The industrial microbiology market has grown strongly in recent years. It will grow from $14.51 billion in 2023 to $15.51 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The expansion observed in the historical period can be attributed to factors such as the increased demand for biopharmaceuticals, the globalization of the pharmaceutical industry, a heightened focus on food safety, environmental monitoring, and quality control in the beverage industry.

The industrial microbiology market is expected to see strong growth in the next few years. It will grow to $20.35 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The anticipated growth in the forecast period can be attributed to increased bioprocessing in agriculture, a rising demand for personalized medicine, expanding applications in energy production, stringent regulatory standards, and increasing global health concerns. Key trends expected in the forecast period involve the emergence of new biotechnologies, digitalization and automation, technological advancements, the development of customized microbial solutions, and increased collaborations and partnerships.

The anticipated growth of the industrial microbiology market is being propelled by increased investment in Research and Development (R&D) by pharmaceutical companies. R&D investment involves the financial commitment made by companies to develop, design, and enhance their offerings. Such increased investments foster innovation and productivity, leveraging microbiology to advance healthcare, nutrition, and environmental initiatives. As reported by the European Federation of Pharmaceutical Industries and Associations, European health industries invested approximately €188.7 billion ($206 billion) in R&D in 2020, accounting for 20.8% of the world's total business R&D expenditure. Furthermore, the UK government declared in March 2022 its commitment to increase R&D investment by £5 billion ($5.51 billion) to reach £20 billion ($22.05 billion) annually by 2024/25, contributing to the overall goal of achieving 2.4% of GDP for R&D investment from all sectors by 2027. Therefore, the heightened R&D investment in pharmaceutical companies is poised to drive the growth of the industrial microbiology market.

The expanding demand for cloud adoption is a key driver propelling the growth of the industrial microbiology market. Cloud adoption involves the increased utilization of cloud computing services and resources across individuals, businesses, and organizations. Embracing cloud technology in industrial microbiology provides a flexible and potent infrastructure supporting data-intensive research, collaborative endeavors, and the application of advanced technologies. This shift towards cloud adoption is expected to accelerate discoveries, enhance efficiency, and augment capabilities within the field of industrial microbiology. A report by CloudZero indicates that Small and Medium Enterprises (SMEs) allocated 47% of their IT budgets to cloud services, representing a 67% increase from 2021 to 2022. Consequently, the surge in cloud adoption is a driving force behind the growth of the industrial microbiology market.

Technological advancements represent a prominent trend in the industrial microbiology market, with major players focusing on introducing new and advanced technologies to fortify their market position. Becton, Dickinson, and Company, a US-based medical technology company, unveiled the BD Kiestra IdentifA system in January 2022. This system utilizes Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-ToF) and automated colony technology to automate microbiological bacterial identification testing preparation. By automating time-consuming manual tasks, the BD Kiestra IdentifA system, in conjunction with BD Synapsys informatics, aims to minimize the risk of human errors during sample preparation for bacterial identification, leading to more accurate diagnoses.

Major companies operating in the industrial microbiology market are introducing innovative products such as the RapiScreen Beverage Kit to enhance their profitability. Hygiena, a US-based company, launched the RapiScreen Beverage Kit in April 2022. This ultra-rapid, high-performance microbiological screening system is specifically designed for low pH beverages, such as teas, energy drinks, fruit juices, UHT pasteurized goods, smoothie mixes, and sauces. The kit reduces product hold time from 4-10 days to 1-2 days, delivering quality control results in less than 30 minutes after an initial incubation period. Employing ATP bioluminescence, an industry-standard technique for checking dairy and beverage products for microbiological contamination, the RapiScreen Kit is backed by the Innovate System, allowing the analysis of up to 96 samples simultaneously and significantly expediting the detection of microbial contamination compared to traditional culture methods.

In November 2022, IDEXX, a US-based provider of rapid microbiology testing services, acquired Tecta-PDS for an undisclosed amount. This strategic acquisition equips IDEXX with an innovative automated microbiology testing platform aimed at ensuring safe and clean water globally. Tecta-PDS, a US-based water safety testing company, operates within the industrial microbiology market.

Major companies operating in the industrial microbiology market report are Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., The Merck Group, Becton Dickinson and Company, Asiagel Corporation, Eppendorf Group, bioMérieux SA, Novamed Ltd., QIAGEN N.V., Sartorius AG, 3M Company, Agilent Technologies Inc., vermicon AG, Eurofins Scientific SE, MilliporeSigma, Hardy Diagnostics, Neogen Corporation, HiMedia Laboratories, BioConnections, Biomerica Inc., Bruker Corporation, Charles River Laboratories International Inc., GENEWIZ Inc., Luminex Corporation, Microbiologics Inc., Promega Corporation, Q Laboratories Inc., Rapid Micro Biosystems Inc., Shimadzu Corporation, TSI Incorporated.

North America was the largest region in the industrial microbiology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global industrial microbiology market report during the forecast period. The regions covered in the industrial microbiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the industrial microbiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary products within the field of industrial microbiology include equipment and systems, reaction consumables, and laboratory supplies. Equipment and systems encompass various assemblies and components used in industrial microbiology processes. These tools are employed in the manufacturing of key substances such as vaccines, food products, enzymes, and other items. Industrial microbiology equipment and systems are integral in performing tests such as sterility testing, microbial limits testing, bio-burden testing, water and environmental testing. These tests find applications in diverse industries such as food and beverages, pharmaceutical biotechnology, agriculture, environmental science, cosmetics, personal care, and others.

The industrial microbiology market research report provides industrial microbiology market statistics, including the industrial microbiology industry's global market size, regional shares, competitors with an industrial microbiology market share, detailed industrial microbiology market segments, market trends, and opportunities, and any further data you may need to thrive in the industrial microbiology industry. This industrial microbiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The industrial microbiology market consists of revenues earned by entities by providing services such as production hygiene and final product testing, preservation system design and evaluation, testing and validation of disinfectants and treated articles, and efficacy data generation for product registration. The market value includes the value of related goods sold by the service provider or included within the service offering. The industrial microbiology market also includes sales of slides, test tubes, petri dishes, solid and liquid growth mediums, inoculation loops, pipettes and tips, incubators, autoclaves, and laminar flow hoods, which are used in providing industrial microbiology services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.